Kathy joined Thomas, McNerney & Partners in 2003 from Piper Jaffray, where she was a health care analyst focused on medical technology companies. Her background also includes experience in new product development at Solvay, S.A. (in a division that is now part of Pfizer). Kathy was also a Senior Scientist in molecular biology at the University of Minnesota, where she worked on the development of molecular biology based assays for the detection of infectious agents. Kathy is currently a board member of AxioMed Spine Corporation, CAS Medical Systems, Inc. (CASM) and VertiFlex, Inc. She is also the President of the Mid-America Health Care Investors Network (MHIN). Her educational background includes an M.S. degree in Microbiology from the University of Minnesota and an M.B.A. from the University of Minnesota’s Carlson School of Management.